Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Toshimasa Ohnishi"'
Autor:
Yuki Kawai, Yoshiyuki Toya, Hiromichi Wakui, Tetsuya Fujikawa, Eiko Ueda, Kengo Azushima, Sho Kinguchi, Hiroshi Mitsuhashi, Tomoyuki Kawano, Tadashi Kuji, Satoshi Yamaguchi, Toshimasa Ohnishi, Kouichi Tamura
Publikováno v:
Journal of Pharmacological Sciences, Vol 147, Iss 1, Pp 118-125 (2021)
Our previous randomized controlled trial comparing the total dose of weekly versus biweekly continuous erythropoietin receptor activator (CERA) therapy to maintain optimal hemoglobin (Hb) levels showed no significant differences between the two thera
Externí odkaz:
https://doaj.org/article/bc8b5ab08cbb441db2084058f0dfc4de
Autor:
Yuki Kawai, Yoshiyuki Toya, Hiromichi Wakui, Tetsuya Fujikawa, Eiko Ueda, Kengo Azushima, Hiroshi Mitsuhashi, Tomoyuki Kawano, Tadashi Kuji, Satoshi Yamaguchi, Toshimasa Ohnishi, Kouichi Tamura
Publikováno v:
The Journal of Clinical Hypertension, Vol 23, Iss 4, Pp 870-878 (2021)
Abstract Although continuous erythropoietin receptor activators (CERAs) are widely used erythropoiesis‐stimulating agents for correcting renal anemia in patients undergoing hemodialysis (HD), few reports have examined weekly CERA administration. In
Externí odkaz:
https://doaj.org/article/62f0e25c3ca842bebc112335d5734937
Autor:
Tomoyuki Kawano, Tadashi Kuji, Tetsuya Fujikawa, Eiko Ueda, Midori Shino, Satoshi Yamaguchi, Toshimasa Ohnishi, Kouichi Tamura, Nobuhito Hirawa, Yoshiyuki Toya
Publikováno v:
Renal Replacement Therapy, Vol 3, Iss 1, Pp 1-7 (2017)
Abstract Background We recently demonstrated, using an index of recently synthesized hemoglobin, reticulocyte hemoglobin (Ret-Hb), that iron administration remarkably improves hemoglobin (Hb) synthesis during the period of high activation of erythrop
Externí odkaz:
https://doaj.org/article/cd4d21e118bb473fb4ed37f0a4b7bf8b
Autor:
Daisuke Kanai, Hiromichi Wakui, Tatsuya Haze, Kengo Azushima, Sho Kinguchi, Tomohiko Kanaoka, Yoshiyuki Toya, Nobuhito Hirawa, Hideaki Kato, Kazushi Uneda, Fumimasa Watanabe, Kanako Hanaoka, Masaaki Hanaoka, Hiroshi Mitsuhashi, Satoshi Yamaguchi, Toshimasa Ohnishi, Kouichi Tamura
Publikováno v:
Kidney International Reports. 7:2718-2721
Autor:
Daisuke Kanai, Hiromichi Wakui, Masaaki Hanaoka, Tatsuya Haze, Kengo Azushima, Satoru Shinoda, Shunichiro Tsukamoto, Shinya Taguchi, Sho Kinguchi, Tomohiko Kanaoka, Yoshiyuki Toya, Nobuhito Hirawa, Hideaki Kato, Fumimasa Watanabe, Kanako Hanaoka, Hiroshi Mitsuhashi, Satoshi Yamaguchi, Toshimasa Ohnishi, Kouichi Tamura
Publikováno v:
Clinical and Experimental Nephrology.
Autor:
Moe Ozawa, Nobuhito Hirawa, Tatsuya Haze, Aiko Haruna, Rina Kawano, Shiro Komiya, Yuki Ohki, Shota Suzuki, Yusuke Kobayashi, Akira Fujiwara, Sanae Saka, Masaaki Hanaoka, Hiroshi Mitsuhashi, Satoshi Yamaguchi, Toshimasa Ohnishi, Kouichi Tamura
Publikováno v:
Clinical and experimental nephrology.
Background Chronic kidney disease–mineral and bone disorder (CKD–MBD), nutritional status, and uremia management have been emphasized for bone management in hemodialysis patients. Nevertheless, valuable data on the importance of muscle mass in bo
Autor:
Hiromichi Wakui, Hiroshi Mitsuhashi, Tetsuya Fujikawa, Kengo Azushima, Yuki Kawai, Toshimasa Ohnishi, Eiko Ueda, Tadashi Kuji, Kouichi Tamura, Yoshiyuki Toya, Sho Kinguchi, Satoshi Yamaguchi, Tomoyuki Kawano
Publikováno v:
Journal of Pharmacological Sciences, Vol 147, Iss 1, Pp 118-125 (2021)
Our previous randomized controlled trial comparing the total dose of weekly versus biweekly continuous erythropoietin receptor activator (CERA) therapy to maintain optimal hemoglobin (Hb) levels showed no significant differences between the two thera
Autor:
Tetsuya Fujikawa, Hiromichi Wakui, Kengo Azushima, Tomoyuki Kawano, Satoshi Yamaguchi, Hiroshi Mitsuhashi, Toshimasa Ohnishi, Kouichi Tamura, Eiko Ueda, Tadashi Kuji, Yoshiyuki Toya, Yuki Kawai
Publikováno v:
The Journal of Clinical Hypertension
Although continuous erythropoietin receptor activators (CERAs) are widely used erythropoiesis‐stimulating agents for correcting renal anemia in patients undergoing hemodialysis (HD), few reports have examined weekly CERA administration. In this ran
Autor:
Moe Ozawa, Nobuhito Hirawa, Aiko Haruna, Tatsuya Haze, Rina Kawano, Shiro Komiya, Yuki Ohki, Yusuke Kobayashi, Akira Fujiwara, Sanae Saka, Masaaki Hanaoka, Hiroshi Mitsuhashi, Satoshi Yamaguchi, Toshimasa Ohnishi, Kouichi Tamura
Publikováno v:
Journal of Hypertension. 41:e387
Autor:
Eiko Ueda, Toshimasa Ohnishi, Naoyuki Kobayashi, Yoshiyuki Toya, Tadashi Kuji, Yoko Itoh, Midori Shino, Nobuhito Hirawa, Tatsuo Hashimoto, Kouichi Tamura, Shota Suzuki, Tetsuya Fujikawa
Publikováno v:
Therapeutic Apheresis and Dialysis. 22:476-484
Oxidative stress accelerates the development of cardiovascular disease. Plasma cystine, a thiol oxidative stress marker, is related to several established factors for cardiovascular disease risk and prognosis. Although a comprehensive oxidative stres